title: How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
authors.affiliation: Royal Marsden Hospital.
authors.forename: R
authors.initials: R
authors.lastname: Powles
authors.forename: J
authors.initials: J
authors.lastname: Treleaven
authors.forename: J
authors.initials: J
authors.lastname: Millar
authors.forename: E C
authors.initials: EC
authors.lastname: Gordon-Smith
authors.forename: C
authors.initials: C
authors.lastname: Tiley
authors.forename: M
authors.initials: M
authors.lastname: Findlay
authors.forename: C
authors.initials: C
authors.lastname: Teo
authors.forename: A
authors.initials: A
authors.lastname: Duncombe
authors.forename: G
authors.initials: G
authors.lastname: Robinson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology / Q000379:methods; D003131:Combined Modality Therapy; D006086:Graft vs Host Disease / Q000276:immunology*; D006648:Histocompatibility; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000601:surgery*; D015993:Life Tables; D008212:Lymphocyte Depletion; D008558:Melphalan / Q000627:therapeutic use*; D012074:Remission Induction; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation
chemical_list: D008558:Melphalan